BackDoseology Sciences Overview

Doseology Sciences Operating Income

Latest operating income for DOSEF: $-1.2M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-420558.00
↑ 412.39% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-1188303.00
↑ 254.61% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Doseology Sciences (DOSEF) FAQ

Doseology Sciences (DOSEF) currently reports a operating income of $-1.2M as of March 2026. That compares with $-340K in the prior-year period — down 254.6% year over year. Use the charts on this page to explore Doseology Sciences's operating income history and peer comparisons.

Doseology Sciences's operating income decreased from $-340K to $-1.2M — a 254.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Doseology Sciences reported $-1.2M in operating income as of March 2026. That compares with $-340K in the prior-year period — down 254.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-1.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Doseology Sciences, and consider following DOSEF for alerts when major investors trade the stock.